To include your compound in the COVID-19 Resource Center, submit it here.

Arena grants newco Everest Chinese rights to candidates

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) granted Everest Medicines Ltd. (Boston, Mass.) exclusive rights to develop and commercialize ralinepag (APD811) and etrasimod

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE